Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Studies of Insulin and Glucagon Action in the Liver [Phase 1, Phase 2]

View source ↗

Summary

A Duke University trial studying insulin and glucagon action in the liver for diabetes, currently in Phase 1/Phase 2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)
  • Insulin (insulin)

Snippet

Sponsor: Duke University | Conditions: Diabetes (DM) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING